14 Apr 2022 Mithra announces improved consolidated topline results from Donesta® Phase 3 studies and launch of recruitment for the extension of European study Member news
05 Apr 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Member news
05 Apr 2022 Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19 Member news
29 Mar 2022 Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth Member news
22 Mar 2022 argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis Member news
10 Mar 2022 Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain Member news
17 Feb 2022 miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study Member news
04 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
